Alzheimer's Drug Discovery Foundation Investor
The Alzheimer's Drug Discovery Foundation (ADDF) is a public charity that focuses on funding innovative research for finding effective drugs for Alzheimer's disease. They provide funding to leading scientists who are conducting promising drug research worldwide. The ADDF follows a biomedical venture philanthropy approach, investing in drug discovery and development programs in academic institutions and biopharmaceutical companies. Since its establishment in 1998, the ADDF has invested nearly $100 million to support over 500 programs across 18 countries.
Founded Date:
1998
Headquarters:
New York, New York, United States
Investor Type:
Donors








